Hospira Worldwide Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA WORLDWIDE, and what generic and branded alternatives to HOSPIRA WORLDWIDE drugs are available?
HOSPIRA WORLDWIDE has one approved drug.
Summary for Hospira Worldwide
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Hospira Worldwide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Worldwide | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 078813-001 | Aug 7, 2009 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hospira Worldwide | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 078813-002 | Aug 7, 2009 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
